Hematology

Molecular diagnostics is a rapidly evolving and dynamic field, representing the fastest-growing segment within the in vitro diagnostics (IVD) market. It has become an indispensable tool in clinical medicine, influencing various aspects of healthcare such as early identification of antimicrobial resistant (AMR) infections, companion diagnostics for cancer treatment, pharmacokinetics for HIV, psychiatric conditions, and blood…

Kalorama Information presents the Clinical Laboratory Services Market, 6th Edition, a comprehensive analysis of the clinical laboratory industry and the trends fueling its growth. This report offers detailed statistics and insights into the factors influencing the industry, including disease incidence in the U.S. and worldwide demographics, life expectancy, and strategic initiatives by major companies.

 

…

Kalorama Information’s United States Market for In Vitro Diagnostic (IVD) Tests, 3rd Edition provides a comprehensive and insightful analysis of the IVD market in the U.S. This market, the largest in the world, is undergoing significant changes influenced by various factors, including the profound impact of COVID-19.

Market Dynamics:

Explore the current state and…

Diagnostic test products have never been more critical. Kalorama Information’s report, 2021 IVD Market Update and COVID-19 Impact, provides an updated analysis of the in vitro diagnostics (IVD) market, reflecting the latest information from our analysts. This comprehensive report includes market sizing for various IVD categories and examines the major trends and impacts of COVID-19…

In vitro diagnostic (IVD) test volumes are crucial for assessing market opportunities for new entrants with diagnostic products and beneficial for existing product marketers. Kalorama’s In Vitro Diagnostic (IVD) Procedure Volumes, 2020-2025 delivers comprehensive market analysis, saving time with detailed calculations and estimates for the current and future number of diagnostic tests across multiple categories.…

Description:

The past few years have seen extraordinary advances in artificial intelligence (AI) in clinical medicine. More products have been cleared for clinical use, more new research-use-only applications have come to market, and many more are in development. In recent years, diagnostics companies, in collaboration with AI companies, have begun implementing increasingly sophisticated machine learning…

This report provides an insightful update on the global in vitro diagnostics (IVD) market, analyzing various factors shaping its current landscape. Covering a span from 2019 to 2024, key topics include:

• Market Developments in Key Regions: North America, EU15/Western Europe, Eastern Europe, Japan, and China
• Examination of Genetic Testing Trends
• Insights into New Point-of-Care…

HbA1c testing has become a critical component in the detection and monitoring of diabetes, leading to a highly competitive and rapidly growing market within the in vitro diagnostics (IVD) industry. With increasing global expenditures on both professional and self-testing HbA1c assays, the market is flourishing. Over a dozen companies are actively producing analyzers, reagents, workstations,…